Sorafenib N-oxide blocks the activity of platelet-derived growth factor receptors (PDGFR), which play a crucial role in cell growth, angiogenesis, and tissue.
Molecular Weight
480.8
Molecular Formula
C21H16ClF3N4O4
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Sorafenib N-oxide functions as a PDGFR inhibitor in research on cancer treatment mechanisms targeting PDGFR signaling.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
